Knowledge, Attitudes, and Practices of European Healthcare Professionals towards Hepatitis A and Hepatitis B Vaccination in at-Risk Adults

被引：2

作者：

Shamarina, Dasha ^{[1
]}

Sluga-O'Callaghan, Martina ^{[2
]}

Kassianos, George ^{[3
,4
]}

Marijam, Alen ^{[1
]}

Dave, Vaidehi ^{[5
]}

Davenport, Eric ^{[5
]}

Andani, Anar ^{[1
]}

Curran, Desmond ^{[1
]}

Dewda, Pavitra ^{[1
]}

Steffen, Robert ^{[6
,7
]}

机构：

[1] GSK, B-1300 Wavre, Belgium

[2] RTI Hlth Solut, F-69009 Lyon, France

[3] Royal Coll Gen Practitioners, London NW1 2FB, England

[4] British Global & Travel Hlth Assoc, London BA1 2SA, England

[5] RTI Hlth Solut, Durham, NC 27709 USA

[6] Univ Zurich, Epidemiol Biostat & Prevent Inst, WHO Collaborating Ctr TravellersHealth, CH-8001 Zurich, Switzerland

[7] Univ Texas Houston, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA

来源：

VACCINES | 2023年 / 11卷 / 11期

关键词：

Europe; guideline; immunization; outbreak; perceived risk; public health; recommendations; survey; vaccine hesitancy; OUTBREAK; MEN; SEX;

D O I：

10.3390/vaccines11111645

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Despite the occurrence of several hepatitis A (hepA) and hepatitis B (hepB) outbreaks in Europe in the last few decades, not all European countries have implemented hepA and hepB vaccinations in their national immunization programs, especially for adults at risk for hepA and/or hepB infection, such as men who have sex with men or patients with chronic liver disease. Currently, little is known on the attitudes of European healthcare professionals (HCPs) towards hepA and hepB vaccinations for at-risk adults. We conducted an online survey among HCPs in Germany, Spain, and the United Kingdom to assess their awareness of and adherence to their national hepA and hepB vaccination guidelines for at-risk adults. Among the 698 HCPs who took the survey, most (91.1%) were familiar with their national vaccination recommendations and always followed them or followed them most of the time when advising or prescribing hepA or hepB vaccines. Major and moderate barriers for recommending or administering such vaccines were the non-disclosure of risk factors by the patient (53.0-57.6%) and the patient's lack of motivation or knowledge about the risk of the disease (50.3-52.9%). These results may help inform strategies to improve and accelerate hepA and hepB vaccination in European at-risk adults.

引用

页数：19